PARTICIPANT TRACKER IN DELHI

Participant Tracker designed around Delhi's clinical research ecosystem

KEY TAKEAWAY

Connect study teams, research sites and participants with practical organize participant progress and study milestones suited to the scale and complexity of clinical research in Delhi.

1M+
Patient Cases Handled
40+
Client Audits
1.5M
Clinical Hours Invested
10M+
Patient Case Records Created
0+
Years with EDC Systems
PROVEN SCALE — NOW SERVING DELHI
PTM · SERVING DELHI

Clinical Research Context in Delhi

Delhi/NCR is one of India’s largest clinical-research markets. The source register snapshot lists 332 studies with New Delhi sites. AIIMS New Delhi operates a Clinical Research Unit and documents clinical-trial and translational-research activity. The source also identifies Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research as part of the research ecosystem. Clinical research activity changes over time, so this page uses a September 2026 snapshot as market context rather than a permanent study count.

The wider Delhi clinical-research ecosystem includes AIIMS New Delhi, Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research. These organizations are cited as examples of the local research environment and are not eTrialTrack customers unless a documented customer relationship exists.

Enrollment Status
Participant Milestones
Visit Scheduling
Follow-Up Tracking
Task Visibility
Participant-Level Progress
Study-Level Visibility
Connected Product Workflows
RETENTION UPLIFT
+38%
Average across active customer deployments

How Can Participant Tracker Support Clinical Trials in Delhi?

For organizations operating in Delhi, the relevant technology question is not simply whether a digital platform is available, but whether it can support the operational requirements of the study. eTrialTrack Participant Tracker can be evaluated for workflows involving high-volume tertiary research, oncology and complex studies, participant tracking, electronic data capture and remote participant workflows. The product is designed to provide organize participant progress and study milestones through enrollment status, visits, follow-up, milestones, tasks and participant-level operational visibility. The exact configuration should be determined by protocol requirements, organizational procedures, user roles, integrations and implementation scope.

Why Consider eTrialTrack?

Organizations in Delhi can evaluate eTrialTrack Participant Tracker when they need a practical workflow that can be configured around their study rather than a generic process. Relevant product capabilities include Enrollment Status; Participant Milestones; Visit Scheduling; Follow-Up Tracking; Task Visibility; Participant-Level Progress; Study-Level Visibility; Connected Product Workflows. Where appropriate, the module can connect with other eTrialTrack capabilities to create a more coherent participant, site and data workflow.

A Practical Local Implementation Approach

A typical discussion for a Delhi study can begin with study requirements, participant and site workflows, data responsibilities, user roles, integrations, implementation timelines and support expectations. From there, the relevant eTrialTrack capabilities can be configured and evaluated against the study requirements.

Local Research Ecosystem

AIIMS New Delhi, Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research. These names describe the broader market context only and should not be presented as customers, partners or users of eTrialTrack without documented evidence.

Important Scope

eTrialTrack Participant Tracker is a technology capability, not a substitute for the approved protocol, investigator responsibilities, ethics requirements, applicable regulations, quality procedures or clinical judgment. Product suitability should be assessed against the specific study and documented requirements.

AUDIENCE & USE CASES

Who uses eTrialTrack Participant Tracker in Delhi

For research teams in Delhi, the Participant Tracker module fits specific roles and study situations — here's who it serves, what it supports, and when to adopt it.

WHO IT'S FOR
  • Pharmaceutical companies and CROs operating in Delhi
  • Investigator sites and hospitals across Delhi's research ecosystem
  • Recruitment and retention teams watching enrollment funnels
  • Coordinators managing screening-to-completion journeys
USE CASES IT SUPPORTS
  • End-to-end participant journey tracking with adherence signals
  • Visit schedules, stipends and milestone management
  • Early dropout-risk flags so teams intervene in time
WHEN YOU NEED IT
  • When long studies lose participants between touchpoints
  • When enrollment status lives in spreadsheets and phone calls
  • When you want local implementation support — onboarding and training aligned to IST, wherever your sites are
FAQS

Clinical Trial Participant Tracker Software in Delhi — frequently asked questions

What does the Clinical Trial Participant Tracker Software do for Delhi clinical trials?

eTrialTrack Participant Tracker provides an organized participant-level operational view across screening, enrollment, visits, follow-up and study milestones. The focus is operational visibility rather than clinical decision-making.

Is the PTM module compliant for Delhi-based studies?

Yes — eTrialTrack is FDA 21 CFR Part 11, ICH-GCP, HIPAA and GDPR compliant, with complete audit trails and e-signatures accepted by Indian (CDSCO) and global regulators.

How quickly can our Delhi team deploy the Clinical Trial Participant Tracker Software?

Most teams go live in 2-4 weeks, including configuration, validation support and team training in IST.

Can we get a Delhi demo of the PTM module?

Absolutely — book a 30-minute guided walkthrough and we will tailor it to your Delhi study setup and protocols.